A Japanese pharmaceutical group focused on developing and commercializing treatments in areas such as neuroscience, nephrology, and oncology, with a global portfolio spanning prescription drugs and clinical nutrition products. Its operations include well-known therapies such as antipsychotic and kid...
1 member of Congress has disclosed 1 trade in 457834 (GMT), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-05-27 | Thomas MacArthur | sell | $1K – $15K |